THE EFFECT OF FENOLDOPAM, A DOPAMINERGIC AGONIST, ON RENAL HEMODYNAMICS

被引：56

作者：

ALLISON, NL

DUBB, JW

ZIEMNIAK, JA

ALEXANDER, F

STOTE, RM

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 03期

关键词：

D O I：

10.1038/clpt.1987.29

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：282 / 288

页数：7

共 32 条

[1]

ACKERMAN DM, 1983, FED PROC, V42, P186

[2]

BLUMBERG A, 1986, CLIN PHARMACOL THER, V39, P181

[3]

BOPPANA VK, 1984, J CHROMATOGR, V317, P463, DOI 10.1016/S0021-9673(01)91686-3

[4] SITES OF ACTION OF TRIPAMIDE [J].

BRATER, DC ;

ANDERSON, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :79-85

[5] SELECTIVE PERIPHERAL DOPAMINE-1 RECEPTOR STIMULATION WITH FENOLDOPAM IN HUMAN ESSENTIAL-HYPERTENSION [J].

CAREY, RM ;

STOTE, RM ;

DUBB, JW ;

TOWNSEND, LH ;

ROSE, CE ;

KAISER, DL .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2198-2207

[6] DOPAMINERGIC INHIBITION OF METOCLOPRAMIDE-INDUCED ALDOSTERONE SECRETION IN MAN - DISSOCIATION OF RESPONSES TO DOPAMINE AND BROMOCRIPTINE [J].

CAREY, RM ;

THORNER, MO ;

ORTT, EM .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (01) :10-18

[7] PERIPHERAL DOPAMINE-RECEPTORS - POTENTIAL TARGETS FOR A NEW CLASS OF ANTIHYPERTENSIVE AGENTS .1. SUBCLASSIFICATION AND FUNCTIONAL DESCRIPTION [J].

CAVERO, I ;

MASSINGHAM, R ;

LEFEVREBORG, F .

LIFE SCIENCES, 1982, 31 (10) :939-948

[8]

GELLAI M, 1985, FED PROC, V44, P1102

[9]

GOLDBERG LI, 1986, FASEB J, V45, P195

[10]

GOLDBERG M, 1985, J CARDIOVASC PHARM, V7, pS34

← 1 2 3 4 →